Ibuprofen And Pseudoephedrine Hydrochloride Farmalider (Pseudoephedrine Hydrochloride, Ibuprofen)

Ibuprofen blocks the cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which are essential for prostaglandin production. By lowering prostaglandin levels, it diminishes inflammation, alleviates pain, and reduces fever. This action complements pseudoephedrine’s decongestant effect, providing comprehensive symptom relief.

The appropriate dose is determined by the prescribing healthcare professional based on the patient’s age, weight, medical condition, and other medications. Patients should follow the prescriber’s instructions and never exceed the recommended amount.

Safety in pregnancy and lactation has not been definitively established for this combination. Healthcare providers usually weigh the potential benefits against possible risks. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their clinician before using the product.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Compared with separate ibuprofen and pseudoephedrine products, this fixed‑dose combination reduces the number of tablets a patient must take, improving convenience and adherence. However, it may not be suitable for patients who need only one of the two components or who have contraindications to either ingredient.

Store the tablets at ambient temperature, preferably below 25 °C. Keep them in the original container, protect from moisture and direct sunlight, and ensure they are out of reach of children.

The product is intended for oral administration. Swallow the tablet whole with a full glass of water, preferably after a meal to minimize stomach irritation, unless the prescriber advises otherwise.

Serious risks include severe allergic reactions (e.g., rash, swelling, breathing difficulty), gastrointestinal bleeding, and significant elevation of blood pressure. Patients experiencing any of these symptoms should seek immediate medical attention.

Individuals with known hypersensitivity to ibuprofen, other NSAIDs, or pseudoephedrine; patients with active peptic ulcer disease, uncontrolled hypertension, severe coronary artery disease, or certain arrhythmias should avoid this medication unless specifically directed by a physician.